KATHRYN GREEN: Open Payments
NPI 1962892844 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,757 in 35 payments from 7 companies in 2025. Trend: 2023 $32,864 · 2024 $28,777 · 2025 $19,757
Speaker / faculty: $17,000Travel & lodging: $1,712Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $19,222 |
| Eisai Inc. | 1 | $104 |
| Intera Oncology, Inc | 1 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $96 |
| Daiichi Sankyo Inc. | 1 | $84 |
| Caris MPI, Inc. | 3 | $78 |
| Ipsen Biopharmaceuticals, Inc | 1 | $69 |
Products named: IMFINZI, Lenvima, INTERA, Stivarga, MI CANCER SEEK, Onivyde.
Industry payments across PA — which companies pay providers there.
